# Adjunctive Everolimus (RAD 001) Therapy for Epilepsy in Children With Sturge-Weber Syndrome (SWS)

> **NCT01997255** · PHASE2 · WITHDRAWN · sponsor: **Baylor College of Medicine**

## Conditions studied

- Sturge Weber Syndrome

## Interventions

- **DRUG:** Everolimus

## Key facts

- **NCT ID:** NCT01997255
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-04
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Site did not want to pursue study
- **Last updated:** 2016-05-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01997255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01997255, "Adjunctive Everolimus (RAD 001) Therapy for Epilepsy in Children With Sturge-Weber Syndrome (SWS)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01997255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*